Unique ID issued by UMIN | UMIN000035763 |
---|---|
Receipt number | R000040738 |
Scientific Title | An evaluation of the change of plasma DHA concentration after the ingestion of DHA containing food. |
Date of disclosure of the study information | 2019/02/04 |
Last modified on | 2019/09/24 16:48:59 |
An evaluation of the change of plasma DHA concentration after the ingestion of DHA containing food.
An evaluation of the change of plasma DHA concentration after the ingestion of DHA containing food.
An evaluation of the change of plasma DHA concentration after the ingestion of DHA containing food.
An evaluation of the change of plasma DHA concentration after the ingestion of DHA containing food.
Japan |
Healthy adult
Adult |
Others
NO
To Confirm the change of plasma DHA concentration after the ingestion of DHA containing food
Bio-availability
Plasma DHA concentration
Plasma EPA concentration
Plasma omega 3-fatty acids concentration(DHA and EPA)
Plasma CCK concentration
Plasma GLP-2 concentration
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Placebo
2
Prevention
Food |
Subjects receive a single dose of the active food. After the washout period (more than 6 days), subjects receive a single dose of the placebo food.
Subjects receive a single dose of the placebo food. After the washout period (more than 6 days), subjects receive a single dose of the active food.
20 | years-old | <= |
35 | years-old | >= |
Male
1) Subjects giving written informed consent
2)Males aged 20 to 35 years old when consent acquisition
3)Subjects whose body mass index (BMI) is from 18.5 kg/m2 to 25.0 kg/m2
1)Subjects who routinely use pharmaceuticals, quasi-drugs and dietary supplement, and consume food for specified health uses more than two days per week
2) Subjects who have chronic diseases necessitating treatments and/or medications
3) Subjects who have significant abnormal blood pressure or blood test score
4) Subjects who have food allergy
5) Subjects who have lactose intolerance
6)Subjects who have digestive diseases or who received digestive surgical procedures
7) Subjects who are habitual smokers within a month of study enrollment
8) Subjects who donate 200 mL of blood within a month, or 400 mL of blood within three month
9) Subjects who participate in other clinical trials within the past month or have plans to participate in other clinical trials during this study period
10)Subjects who determine ineligible by the principal investigator or sub-investigator
10
1st name | |
Middle name | |
Last name | Keiko Kawahata |
Meiji Co.,Ltd.
Food Science & Technology Research Laboratories, R&D Division
1-29-1 Nanakuni, Hachiouji, Tokyo
042-632-5847
keiko.kawahata@meiji.com
1st name | |
Middle name | |
Last name | Yusuke Omae |
Meiji Co.,Ltd.
Food Science & Technology Research Laboratories, R&D Division
1-29-1 Nanakuni, Hachiouji, Tokyo
042-632-5847
yuusuke.ohmae@meiji.com
Meiji CO.,Ltd.
Meiji CO.,Ltd.
Profit organization
NO
チヨダパラメディカルケアクリニック
2019 | Year | 02 | Month | 04 | Day |
Unpublished
Completed
2019 | Year | 01 | Month | 29 | Day |
2019 | Year | 01 | Month | 17 | Day |
2019 | Year | 02 | Month | 03 | Day |
2019 | Year | 03 | Month | 03 | Day |
2019 | Year | 02 | Month | 04 | Day |
2019 | Year | 09 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040738